Jingxuan Li Selected Research

4-amylcinnamoylanthranilic acid

1/2022

TRPM2 Promotes Atherosclerotic Progression in a Mouse Model of Atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingxuan Li Research Topics

Disease

2	Inflammation (Inflammations) 01/2022 - 01/2022
2	Atherosclerosis 01/2022 - 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Carotid Artery Injuries 01/2021
1	Insulin Resistance 01/2019
1	Neoplasms (Cancer) 01/2019
1	Thymoma (Thymic Carcinoma) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Carcinoma (Carcinomatosis) 07/2015

Drug/Important Bio-Agent (IBA)

2	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	oil red OIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	ElastinIBA 01/2022
1	4-amylcinnamoylanthranilic acidIBA 01/2022
1	ApolipoproteinsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Long Noncoding RNAIBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2018
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Glycogen Synthase (Synthase I)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Biological ProductsIBA 07/2015